25 US stocks for 2025: UBS's highest conviction calls

UBS Research lists its top 25 U.S. stock picks for 2025, highlighting firms in various sectors expected to see growth due to strategic moves and market trends.

Drugmaker stocks slide as Trump taps vaccine skeptic RFK Jr for US health job

U.S. drugmaker shares fell after Trump appointed Robert F. Kennedy Jr. to lead health, raising investor concerns over vaccine policies and agency oversight.

Keurig Dr Pepper stock slips as top shareholder JAB sells 60 million shares

Keurig Dr Pepper shares fell over 3.7% after JAB Holding announced a secondary offering of 60 million shares, reducing its ownership stake significantly.

Earnings call: Keurig Dr Pepper reports growth and strategic acquisition

Tesla, UPS, Hasbro and Southwest rise premarket; Boeing and IBM fall

US stock futures rise; key movers include Tesla, Boeing, Southwest Airlines, UPS, and IBM amid various earnings reports and contract negotiations.

Keurig Dr Pepper misses revenue expectations in Q3, stock slips

Keurig Dr Pepper shares dropped over 1% after reporting Q3 revenue of $3.89 billion, slightly below estimates, while reaffirming growth expectations for fiscal 2024.

Keurig Dr Pepper takes majority stake in energy-drink maker Ghost for $990 million

Keurig Dr Pepper is acquiring a 60% stake in Ghost for $990 million, enhancing its presence in the growing U.S. energy drinks market.

Union Pacific, Dow Chemical, UPS lead earnings parade Thursday

A summary of companies reporting earnings on October 24, 2024, including estimates for EPS and revenue for various industry leaders.